Zebrafish an experimental model of Huntington's disease: molecular aspects, therapeutic targets and current challenges

被引:22
作者
Kumar, Vishal [1 ]
Singh, Charan [2 ,3 ]
Singh, Arti [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Moga 142001, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut, Moga 142001, Punjab, India
[3] IK Gujral Punjab Tech Univ, Jalandhar 144603, Punjab, India
关键词
Huntington disease; Neurodegeneration; HD mechanisms; Therapeutic targets; Therapeutic approaches; Zebrafish; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; TRKB RECEPTOR; MOUSE MODEL; IN-VIVO; PROTEIN; AGGREGATION; EXPRESSION; SURVIVAL; ACID;
D O I
10.1007/s11033-021-06787-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a lethal autosomal dominant neurodegenerative disease whose exact causative mechanism is still unknown. It can transform from one generation to another generation. The CAG triplet expansion on polyglutamine (PolyQ) tract on Huntingtin protein primarily contributes in HD pathogenesis. Apart from this some another molecular mechanisms are also involved in HD pathology such as loss of Brain derived neurotrophic factor in medium spiny neurons, mitochondrial dysfunction, and alterations in synaptic plasticity are briefly discussed in this review. However, several chemicals (3-nitropropionic acid, and Quinolinic acid) and genetic (mHTT-Delta N17-97Q over expression) experimental models are used to explore the exact pathogenic mechanism and finding of new drug targets for the development of novel therapeutic approaches. The zebrafish (Danio rerio) is widely used in in-vivo screening of several central nervous system (CNS) diseases such as HD, Alzheimer's disease (AD), Parkinson's disease (PD), and in memory deficits. Thus, this makes zebrafish as an excellent animal model for the development of new therapeutic strategies against various CNS disorders. We had reviewed several publications utilizing zebrafish and rodents to explore the disease pathology. Studies suggested that zebrafish genes and their human homologues have conserved functions. Zebrafish advantages and their characteristics over the other experimental animals make it an excellent tool for the disease study. This review explains the possible pathogenic mechanism of HD and also discusses about possible treatment therapies, apart from this we also discussed about possible potential therapeutic targets which will helps in designing of novel therapeutic approaches to overcome the disease progression. Graphic abstract Diagrammatic depiction shows prevention of HD pathogenesis through attenuation of various biochemical alterations.
引用
收藏
页码:8181 / 8194
页数:14
相关论文
共 100 条
[21]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[22]   Decreased BDNF Levels Are a Major Contributor to the Embryonic Phenotype of Huntingtin Knockdown Zebrafish [J].
Diekmann, Heike ;
Anichtchik, Oleg ;
Fleming, Angeleen ;
Futter, Marie ;
Goldsmith, Paul ;
Roach, Alan ;
Rubinsztein, David C. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (05) :1343-1349
[23]   Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy [J].
Dowling, James J. ;
Arbogast, Sandrine ;
Hur, Junguk ;
Nelson, Darcee D. ;
McEvoy, Anna ;
Waugh, Trent ;
Marty, Isabelle ;
Lunardi, Joel ;
Brooks, Susan V. ;
Kuwada, John Y. ;
Ferreiro, Ana .
BRAIN, 2012, 135 :1115-1127
[24]   Huntingtin Regulates Mammary Stem Cell Division and Differentiation [J].
Elias, Salah ;
Thion, Morgane S. ;
Yu, Hua ;
Sousa, Cristovao Marques ;
Lasgi, Charlene ;
Morin, Xavier ;
Humbert, Sandrine .
STEM CELL REPORTS, 2014, 2 (04) :491-506
[25]   Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review [J].
Essa, Musthafa Mohamed ;
Moghadas, Marzieh ;
Ba-Omar, Taher ;
Qoronfleh, M. Walid ;
Guillemin, Gilles J. ;
Manivasagam, Thamilarasan ;
Justin-Thenmozhi, Arokiasamy ;
Ray, Bipul ;
Bhat, Abid ;
Chidambaram, Saravana Babu ;
Fernandes, Amanda J. ;
Song, Byoung-Joon ;
Akbar, Mohammed .
NEUROTOXICITY RESEARCH, 2019, 35 (03) :739-774
[26]  
Exuzides A, 2020, NEUROTHERAPEUTICS, V17, P8
[27]   Fishing in the Cell Powerhouse: Zebrafish as A Tool for Exploration of Mitochondrial Defects Affecting the Nervous System [J].
Fichi, Gianluca ;
Naef, Valentina ;
Barca, Amilcare ;
Longo, Giovanna ;
Fronte, Baldassare ;
Verri, Tiziano ;
Santorelli, Filippo M. ;
Marchese, Maria ;
Petruzzella, Vittoria .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
[28]   PRESYNAPTIC AND POSTSYNAPTIC NEUROTOXIC EFFECTS OF DOPAMINE DEMONSTRATED BY INTRASTRIATAL INJECTION [J].
FILLOUX, F ;
TOWNSEND, JJ .
EXPERIMENTAL NEUROLOGY, 1993, 119 (01) :79-88
[29]   A study of chorea after tetrabenazine withdrawal in patients with Huntington disease [J].
Frank, Samuel ;
Ondo, William ;
Fahn, Stanley ;
Hunter, Christine ;
Oakes, David ;
Plumb, Sandra ;
Marshall, Frederick ;
Shoulson, Ira ;
Eberly, Shirley ;
Walker, Francis ;
Factor, Stewart ;
Hunt, Vicki ;
Shinaman, Aileen ;
Jankovic, Joseph .
CLINICAL NEUROPHARMACOLOGY, 2008, 31 (03) :127-133
[30]   Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules [J].
Gauthier, LR ;
Charrin, BC ;
Borrell-Pagès, M ;
Dompierre, JP ;
Rangone, H ;
Cordelières, FP ;
De Mey, J ;
MacDonald, ME ;
Lessmann, V ;
Humbert, S ;
Saudou, F .
CELL, 2004, 118 (01) :127-138